MedPath

山东宜岛康制药有限公司

Ownership
-
Established
2018-07-27
Employees
-
Market Cap
-
Website
http://www.chinayidaokang.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

16

NMPA:16

Drug Approvals

七味肝胆清颗粒

Approval Number
国药准字Z20090689
Approval Date
Mar 28, 2024
NMPA

通塞脉颗粒

Approval Number
国药准字Z20184086
Approval Date
Oct 24, 2023
NMPA

Enalapril Maleate and Hydrochlorothiazide Chewable Tablets

Product Name
依那普利氢氯噻嗪咀嚼片
Approval Number
国药准字H20090023
Approval Date
Sep 4, 2023
NMPA

止咳胶囊

Approval Number
国药准字Z20130011
Approval Date
Mar 22, 2023
NMPA

冠心丹参颗粒

Approval Number
国药准字Z10970104
Approval Date
Jan 12, 2023
NMPA

清热明目茶

Approval Number
国药准字Z44022015
Approval Date
Jan 12, 2023
NMPA

八珍袋泡茶

Approval Number
国药准字Z44022013
Approval Date
Jan 12, 2023
NMPA

复方补骨脂颗粒

Approval Number
国药准字Z44022014
Approval Date
Jan 12, 2023
NMPA

杞黄降糖胶囊

Approval Number
国药准字Z20174016
Approval Date
Apr 12, 2022
NMPA

益中生血胶囊

Approval Number
国药准字Z20123008
Approval Date
Nov 8, 2021
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.